Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Patented SentryBond™ technology, a first-of-its-kind abuse-deterrent technology, is designed to provide multiple levels of protection and has the potential to be utilized in other medications